Arcutis Biotherapeutics ARQT Earnings Call Transcripts

NASDAQ ARQT
$27.39 +1.18 (+4.52%)
At close: Nov 10, 2026 · 4:00 PM EST
5 earnings calls on file for Arcutis Biotherapeutics, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Arcutis Biotherapeutics Q3 2026 Earnings Call

Nov 4, 2026 11,628 words · 51 min read
  • Brian SchoelkopfHead of Investor Relations
  • Frank WatanabePresident and Chief Executive Officer
  • Robert LisickiChief Commercial Officer
  • Patrick BurnettChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Arcutis Biotherapeutics Earnings Call Transcripts

Calls5
LatestNov 4, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 5 Arcutis Biotherapeutics transcripts Register to get access to Arcutis Biotherapeutics’s earnings call transcripts.